Clements, M L <br/><br/>
Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection.  [electronic resource] 

 -  Lancet (London, England)  Mar 1984 
 - 705-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0140-6736 
<br/><br/><label>Standard No.: </label>10.1016/s0140-6736(84)92222-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intranasal<br/>Adolescent<br/>Adult<br/>Antibody Formation<br/>Cold Temperature<br/>Humans<br/>Influenza A Virus, H3N2 Subtype<br/>Influenza A virus--genetics<br/>Influenza Vaccines--administration & dosage<br/>Influenza, Human--prevention & control<br/>Injections, Intramuscular<br/>Random Allocation<br/>Vaccines, Attenuated--administration & dosage<br/>Virus Replication